- Home
- INCY vs PAG Comparison
INCY vs PAG Comparison
Compare INCY & PAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INCY
- PAG
- Stock Information
- Founded
- INCY 1991
- PAG 1990
- Country
- INCY United States
- PAG United States
- Employees
- INCY N/A
- PAG N/A
- Industry
- INCY Biotechnology: Commercial Physical & Biological Resarch
- PAG Retail-Auto Dealers and Gas Stations
- Sector
- INCY Health Care
- PAG Consumer Discretionary
- Exchange
- INCY Nasdaq
- PAG Nasdaq
- Market Cap
- INCY 13.0B
- PAG 12.1B
- IPO Year
- INCY 1993
- PAG 1996
- Fundamental
- Price
- INCY $70.20
- PAG $175.22
- Analyst Decision
- INCY Hold
- PAG Buy
- Analyst Count
- INCY 20
- PAG 6
- Target Price
- INCY $72.75
- PAG $174.17
- AVG Volume (30 Days)
- INCY 1.5M
- PAG 221.7K
- Earning Date
- INCY 07-29-2025
- PAG 07-30-2025
- Dividend Yield
- INCY N/A
- PAG 2.86%
- EPS Growth
- INCY N/A
- PAG N/A
- EPS
- INCY 0.10
- PAG 14.19
- Revenue
- INCY $4,413,226,000.00
- PAG $30,611,900,000.00
- Revenue This Year
- INCY $13.48
- PAG $3.32
- Revenue Next Year
- INCY $10.37
- PAG $3.96
- P/E Ratio
- INCY $723.63
- PAG $12.04
- Revenue Growth
- INCY 17.13
- PAG 3.29
- 52 Week Low
- INCY $53.56
- PAG $134.05
- 52 Week High
- INCY $83.95
- PAG $186.33
- Technical
- Relative Strength Index (RSI)
- INCY 55.91
- PAG 52.99
- Support Level
- INCY $67.17
- PAG $169.35
- Resistance Level
- INCY $71.29
- PAG $174.57
- Average True Range (ATR)
- INCY 1.51
- PAG 4.12
- MACD
- INCY 0.06
- PAG -0.98
- Stochastic Oscillator
- INCY 74.23
- PAG 51.95
About INCY Incyte Corp.
Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.
About PAG Penske Automotive Group Inc.
Penske Automotive Group operates in 19 US states and overseas. It has over 150 US and Puerto Rico light-vehicle stores as well as 210 franchised dealerships overseas, primarily in the United Kingdom but also in Australia, Germany, Italy, and Japan. The company is the third-largest US publicly traded dealership in terms of light-vehicle revenue and sells more than 40 brands, with over 90% of retail automotive revenue coming from luxury and import names. Other segments are service and finance and insurance. The firm's Premier Truck Group owns 45 truck dealerships selling mostly Freightliner and Western Star brands, and Penske owns 16 used-vehicle stores, mostly in the US and UK under the CarShop (US) and Sytner Select (UK) brands. Penske is based in Bloomfield Hills, Michigan.